MX2015017418A - Therapeutic nanometric system and uses of the same. - Google Patents

Therapeutic nanometric system and uses of the same.

Info

Publication number
MX2015017418A
MX2015017418A MX2015017418A MX2015017418A MX2015017418A MX 2015017418 A MX2015017418 A MX 2015017418A MX 2015017418 A MX2015017418 A MX 2015017418A MX 2015017418 A MX2015017418 A MX 2015017418A MX 2015017418 A MX2015017418 A MX 2015017418A
Authority
MX
Mexico
Prior art keywords
same
drug
therapeutic
nanometric
nanometric system
Prior art date
Application number
MX2015017418A
Other languages
Spanish (es)
Inventor
Rebeca Gutiérrez Meléndez Alba
Original Assignee
Rebeca Gutiérrez Meléndez Alba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rebeca Gutiérrez Meléndez Alba filed Critical Rebeca Gutiérrez Meléndez Alba
Priority to MX2015017418A priority Critical patent/MX2015017418A/en
Publication of MX2015017418A publication Critical patent/MX2015017418A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present disclosure is related to a nanometric system for the delivery (targeting) of a drug within the vasculature of a tissue, from gold nano-stars that binds with at least one drug, controlled release copolymers, and specific targeting ligands. This system is useful for carrying drugs, such as taxanes, for the cancer treatment leading the same towards the tumor tissues, releasing the drug within the same.
MX2015017418A 2015-12-16 2015-12-16 Therapeutic nanometric system and uses of the same. MX2015017418A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2015017418A MX2015017418A (en) 2015-12-16 2015-12-16 Therapeutic nanometric system and uses of the same.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2015017418A MX2015017418A (en) 2015-12-16 2015-12-16 Therapeutic nanometric system and uses of the same.

Publications (1)

Publication Number Publication Date
MX2015017418A true MX2015017418A (en) 2017-06-15

Family

ID=59684274

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015017418A MX2015017418A (en) 2015-12-16 2015-12-16 Therapeutic nanometric system and uses of the same.

Country Status (1)

Country Link
MX (1) MX2015017418A (en)

Similar Documents

Publication Publication Date Title
PH12017500023A1 (en) Targeted conjugates and particles and formulations thereof
EA201890272A1 (en) AXL-SPECIFIC CONJUGATES ANTIBODY AND MEDICINE FOR THE TREATMENT OF CANCER
MX2017007321A (en) Combination therapies.
PH12019501959A1 (en) Therapeutic rna
EA201790674A1 (en) CYTOTOXIC INDUCING THERAPEUTIC AGENT
MX2018014175A (en) ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE.
MX2022015748A (en) Combination therapy for the treatment of cancer.
MX340090B (en) Spliceostatin analogs.
MX2017003246A (en) Macropinocytosing human anti-cd46 antibodies and targeted cancer therapeutics.
JO3606B1 (en) Androgen receptor modulator in combination with abiraternoe acetate and prednisone for treating prostate cancer
CY1122968T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A DIAMINO-HETEROCYCLIC CARBOXAMIDE COMPOUND AS AN ACTIVE INGREDIENT
MX2017017138A (en) Targeted conjugates of ksp inhibitors.
PH12015502616A1 (en) Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
GB2538023A (en) Targeted drug conjugates
MX2018015172A (en) Methods of treating pancreatic cancer.
MX2018016332A (en) Combination chemotherapies.
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
MX2019003694A (en) Methods of treating biliary tract cancer.
EP3991749A3 (en) A therapeutic agent for a tumor comprising an ido inhibitor administered in combination with an antibody
MX2017010341A (en) Cancer therapy with a parvovirus combined with bevacizumab.
MX2022014792A (en) Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same.
WO2015038896A3 (en) Wilforlide a for overcoming chemotherapy resistance
PH12020500096A1 (en) Therapeutic combination of a third generation egfr tyrosine kinase inhibitor and a raf inhibitor
MX2017009608A (en) Anti-cancer compounds.
MY197664A (en) Immunity enhancing agent for cancer by allergin-1 antagonist